Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes
Release Date:
11/06/2017
... of Autoimmune Diabetes (GPPAD; “gee-pad”) and its first trial – the Primary Oral Insulin Trial (POInT). ...